Kiniksa Pharmaceuticals Appoints Ross Moat as President and COO
Position
President
Company
Kiniksa Pharmaceuticals, Ltd.
LexingtonBiotechnologyHealthcarePharmaceuticalBiopharmaDescription
On October 17, 2026, Kiniksa Pharmaceuticals appointed Ross Moat as President and Chief Operating Officer, effective immediately. Mr. Moat, who has been with the company since June 2019, previously served as the EVP, Chief Operating Officer
Quick answer
Kiniksa Pharmaceuticals Appoints Ross Moat as President and COO (October 22, 2026). Kiniksa Pharmaceuticals, Ltd. is based in Lexington, Massachusetts, United States.
- Who is the new President at Kiniksa Pharmaceuticals, Ltd?
- Kiniksa Pharmaceuticals, Ltd. named Ross Moat President, announced October 22, 2026.
- What did Kiniksa Pharmaceuticals, Ltd. announce on October 22, 2026?
- On October 17, 2026, Kiniksa Pharmaceuticals appointed Ross Moat as President and Chief Operating Officer, effective immediately.
- What does Kiniksa Pharmaceuticals, Ltd. do?
- Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.
- Where is Kiniksa Pharmaceuticals, Ltd. based?
- Kiniksa Pharmaceuticals, Ltd. is based in Lexington, Massachusetts, United States.
- Which similar companies made leadership changes around the same time?
- Retension Pharmaceuticals (October 23, 2026), AbbVie Inc. (November 2, 2026), Syndax Pharmaceuticals (November 2, 2026) and Os Therapies (October 1, 2026) also announced leadership changes within 45 days of Kiniksa Pharmaceuticals, Ltd.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Retension Pharmaceuticals Appoints Robert Wong as Chief Accounting Officer (October 23, 2026)
- AbbVie Director Resigns Following CEO Appointment at Align Technology (November 2, 2026)
- Syndax Pharmaceuticals Appoints Aaron A. Ondrey as Chief Financial Officer (November 2, 2026)
- OS Therapies Appoints Mr. Clem as Chief Commercial Officer and Mr. Knuettel as Chief Financial Officer (October 1, 2026)
- Richard J. Daly Appointed as Director of Aquestive Therapeutics (September 29, 2026)
- Gyre Therapeutics Appoints Ying Luo as CEO and Thomas Eastling as CFO (October 22, 2026)
Who to call at Kiniksa Pharmaceuticals, Ltd., and when
A new leader at Kiniksa Pharmaceuticals, Ltd. brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Kiniksa Pharmaceuticals, Ltd. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kiniksa Pharmaceuticals, Ltd., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kiniksa Pharmaceuticals, Ltd.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kiniksa Pharmaceuticals, Ltd. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Kiniksa Pharmaceuticals, Ltd. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.